Breaking: Pfizer reports Q2 2021 earnings ,beats on EPS and Revenue, raises guidance
|
Pfizer (PFE) reported Q2 2021 earnings on Wednesday, July 28 before the market opened. Pfizer reported Earnings Per Share (EPS) of $1.07 versus the average Wall Street analyst estimate of $0.96.
Revenue was $19 billion versus the average analyst estimate of $18.45 billion.
Pfizer also raised its full-year guidance from $70.5-72.5 billion to $78-80 billion and raises full-year EPS guidance from $3.55-3.65 to $3.95-4.05 range.
Pfizer raised sales forecasts for sales of the Covid-19 vaccine to $33.5 billion from $26 billion.
Pfizer stock forecast
Pfizer (PFE) stock is trading at $42.40 in Wednesday's premarket, a change of 0.7% . Pfizer closed Tuesday's regular session at $42.10, a change of +0.69% on Tuesday.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.